annual cash & cash equivalents:
$555.03M+$72.66M(+15.06%)Summary
- As of today (May 20, 2025), INSM annual cash & cash equivalents is $555.03 million, with the most recent change of +$72.66 million (+15.06%) on December 31, 2024.
- During the last 3 years, INSM annual cash & cash equivalents has fallen by -$161.75 million (-22.57%).
- INSM annual cash & cash equivalents is now -48.32% below its all-time high of $1.07 billion, reached on December 31, 2022.
Performance
INSM Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$403.25M-$151.78M(-27.35%)Summary
- As of today (May 20, 2025), INSM quarterly cash & cash equivalents is $403.25 million, with the most recent change of -$151.78 million (-27.35%) on March 31, 2025.
- Over the past year, INSM quarterly cash & cash equivalents has dropped by -$192.48 million (-32.31%).
- INSM quarterly cash & cash equivalents is now -67.66% below its all-time high of $1.25 billion, reached on June 30, 2024.
Performance
INSM quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
INSM Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +15.1% | -32.3% |
| 3 y3 years | -22.6% | -21.8% |
| 5 y5 years | +13.9% | -6.0% |
INSM Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -48.3% | +15.1% | -67.7% | at low |
| 5 y | 5-year | -48.3% | +15.1% | -67.7% | at low |
| alltime | all time | -48.3% | >+9999.0% | -67.7% | >+9999.0% |
INSM Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $403.25M(-27.3%) |
| Dec 2024 | $555.03M(+15.1%) | $555.03M(+20.3%) |
| Sep 2024 | - | $461.45M(-63.0%) |
| Jun 2024 | - | $1.25B(+109.3%) |
| Mar 2024 | - | $595.73M(+23.5%) |
| Dec 2023 | $482.37M(-55.1%) | $482.37M(-1.0%) |
| Sep 2023 | - | $487.11M(-20.5%) |
| Jun 2023 | - | $612.88M(-36.7%) |
| Mar 2023 | - | $968.91M(-9.8%) |
| Dec 2022 | $1.07B(+49.8%) | $1.07B(+159.0%) |
| Sep 2022 | - | $414.63M(-0.3%) |
| Jun 2022 | - | $416.08M(-19.3%) |
| Mar 2022 | - | $515.70M(-28.1%) |
| Dec 2021 | $716.78M(+34.5%) | $716.78M(-15.3%) |
| Sep 2021 | - | $846.56M(-8.8%) |
| Jun 2021 | - | $928.33M(+126.6%) |
| Mar 2021 | - | $409.75M(-23.1%) |
| Dec 2020 | $532.76M(+9.3%) | $532.76M(-9.5%) |
| Sep 2020 | - | $588.75M(-8.3%) |
| Jun 2020 | - | $641.91M(+49.6%) |
| Mar 2020 | - | $428.94M(-12.0%) |
| Dec 2019 | $487.43M(-1.5%) | $487.43M(-9.0%) |
| Sep 2019 | - | $535.63M(-10.9%) |
| Jun 2019 | - | $601.26M(+43.1%) |
| Mar 2019 | - | $420.23M(-15.1%) |
| Dec 2018 | $495.07M(+29.9%) | $495.07M(-12.8%) |
| Sep 2018 | - | $567.57M(-10.5%) |
| Jun 2018 | - | $634.33M(-7.6%) |
| Mar 2018 | - | $686.58M(+80.1%) |
| Dec 2017 | $381.17M(+134.4%) | $381.17M(-11.5%) |
| Sep 2017 | - | $430.68M(+372.9%) |
| Jun 2017 | - | $91.06M(-27.6%) |
| Mar 2017 | - | $125.84M(-22.6%) |
| Dec 2016 | $162.59M(-42.5%) | $162.59M(-18.9%) |
| Sep 2016 | - | $200.52M(-10.1%) |
| Jun 2016 | - | $223.11M(-11.8%) |
| Mar 2016 | - | $252.87M(-10.6%) |
| Dec 2015 | $282.88M(+77.7%) | $282.88M(-9.0%) |
| Sep 2015 | - | $310.97M(-7.2%) |
| Jun 2015 | - | $335.03M(+149.0%) |
| Mar 2015 | - | $134.55M(-15.5%) |
| Dec 2014 | $159.23M(+39.8%) | $159.23M(-4.8%) |
| Sep 2014 | - | $167.31M(+102.3%) |
| Jun 2014 | - | $82.70M(-18.3%) |
| Mar 2014 | - | $101.25M(-11.1%) |
| Dec 2013 | $113.89M(+25.5%) | $113.89M(-11.0%) |
| Sep 2013 | - | $128.03M(+71.6%) |
| Jun 2013 | - | $74.59M(-6.1%) |
| Mar 2013 | - | $79.43M(-12.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $90.78M(+511.4%) | $90.78M(+101.8%) |
| Sep 2012 | - | $44.99M(+57.4%) |
| Jun 2012 | - | $28.57M(+29.6%) |
| Mar 2012 | - | $22.04M(+48.5%) |
| Dec 2011 | $14.85M(+38.2%) | $14.85M(+42.1%) |
| Sep 2011 | - | $10.45M(+6.2%) |
| Jun 2011 | - | $9.84M(-55.5%) |
| Mar 2011 | - | $22.10M(+105.7%) |
| Dec 2010 | $10.74M(-15.7%) | $10.74M(-5.1%) |
| Jun 2010 | - | $11.32M(-41.6%) |
| Mar 2010 | - | $19.36M(+52.0%) |
| Dec 2009 | $12.74M(+493.9%) | $12.74M(-52.5%) |
| Sep 2009 | - | $26.84M(+1151.2%) |
| Dec 2008 | $2.15M(-87.0%) | $2.15M(-62.8%) |
| Sep 2008 | - | $5.77M(-38.9%) |
| Jun 2008 | - | $9.45M(-21.5%) |
| Mar 2008 | - | $12.03M(-27.0%) |
| Dec 2007 | $16.48M(-31.7%) | $16.48M(-12.9%) |
| Sep 2007 | - | $18.91M(-15.0%) |
| Jun 2007 | - | $22.26M(+84.9%) |
| Mar 2007 | - | $12.04M(-50.1%) |
| Dec 2006 | $24.11M(+28.0%) | $24.11M(-31.1%) |
| Sep 2006 | - | $34.99M(-27.6%) |
| Jun 2006 | - | $48.36M(-18.3%) |
| Mar 2006 | - | $59.21M(+214.3%) |
| Dec 2005 | $18.84M(+104.2%) | $18.84M(-8.9%) |
| Sep 2005 | - | $20.68M(-27.3%) |
| Jun 2005 | - | $28.45M(-20.5%) |
| Mar 2005 | - | $35.77M(+287.9%) |
| Dec 2004 | $9.22M(-68.8%) | $9.22M(+22.8%) |
| Sep 2004 | - | $7.51M(-46.6%) |
| Jun 2004 | - | $14.05M(-43.6%) |
| Mar 2004 | - | $24.91M(-15.6%) |
| Dec 2003 | $29.53M(+8.0%) | $29.53M(-8.3%) |
| Sep 2003 | - | $32.19M(+46.3%) |
| Jun 2003 | - | $22.01M(-12.4%) |
| Mar 2003 | - | $25.12M(-8.1%) |
| Dec 2002 | $27.34M(-46.7%) | $27.34M(-12.3%) |
| Sep 2002 | - | $31.18M(-14.0%) |
| Jun 2002 | - | $36.26M(-14.4%) |
| Mar 2002 | - | $42.37M(-17.3%) |
| Dec 2001 | $51.25M(-28.4%) | $51.25M(-10.6%) |
| Sep 2001 | - | $57.34M(-14.2%) |
| Jun 2001 | - | $66.86M(-7.3%) |
| Mar 2001 | - | $72.12M(+0.7%) |
| Dec 2000 | $71.63M(>+9900.0%) | $71.63M(+143.8%) |
| Sep 2000 | - | $29.37M(-16.4%) |
| Jun 2000 | - | $35.14M(+1243.7%) |
| Mar 2000 | - | $2.62M |
| Dec 1999 | $317.00K | - |
FAQ
- What is Insmed Incorporated annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Insmed Incorporated?
- What is Insmed Incorporated annual cash & cash equivalents year-on-year change?
- What is Insmed Incorporated quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Insmed Incorporated?
- What is Insmed Incorporated quarterly cash & cash equivalents year-on-year change?
What is Insmed Incorporated annual cash & cash equivalents?
The current annual cash & cash equivalents of INSM is $555.03M
What is the all time high annual cash & cash equivalents for Insmed Incorporated?
Insmed Incorporated all-time high annual cash & cash equivalents is $1.07B
What is Insmed Incorporated annual cash & cash equivalents year-on-year change?
Over the past year, INSM annual cash & cash equivalents has changed by +$72.66M (+15.06%)
What is Insmed Incorporated quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of INSM is $403.25M
What is the all time high quarterly cash & cash equivalents for Insmed Incorporated?
Insmed Incorporated all-time high quarterly cash & cash equivalents is $1.25B
What is Insmed Incorporated quarterly cash & cash equivalents year-on-year change?
Over the past year, INSM quarterly cash & cash equivalents has changed by -$192.48M (-32.31%)